Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease

Daniel Montelongo-Jauregui; Taissa Vila; Ahmed S. Sultan; Mary Ann Jabra-Rizk

doi:10.1371/journal.ppat.1008735

Loading metrics

Open Access

Pearls provide concise, practical and educational insights into topics that span the pathogens field.

See all article types »

Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease

Daniel Montelongo-Jauregui ,

* E-mail: dmontelongo@umaryland.edu

Affiliation Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America

http://orcid.org/0000-0001-6079-4277

⨯
Taissa Vila,

Affiliation Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America

http://orcid.org/0000-0001-5600-4367

⨯
Ahmed S. Sultan,

Affiliation Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America

http://orcid.org/0000-0001-5286-4562

⨯
Mary Ann Jabra-Rizk

Affiliations Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America, Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America
⨯

Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease

Daniel Montelongo-Jauregui,
Taissa Vila,
Ahmed S. Sultan,
Mary Ann Jabra-Rizk

Published: August 12, 2020
https://doi.org/10.1371/journal.ppat.1008735

About the Authors

Daniel Montelongo-Jauregui

* E-mail: dmontelongo@umaryland.edu

Affiliation Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America

http://orcid.org/0000-0001-6079-4277

Taissa Vila

Affiliation Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America

http://orcid.org/0000-0001-5600-4367

Ahmed S. Sultan

Affiliation Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America

http://orcid.org/0000-0001-5286-4562

Mary Ann Jabra-Rizk

Affiliations Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America, Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
COVID 19
Is the Subject Area "COVID 19" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Respiratory infections
Is the Subject Area "Respiratory infections" applicable to this article?

Thanks for your feedback.
SARS
Is the Subject Area "SARS" applicable to this article?

Thanks for your feedback.
Blood transfusion
Is the Subject Area "Blood transfusion" applicable to this article?

Thanks for your feedback.
Elimination half-life calculation
Is the Subject Area "Elimination half-life calculation" applicable to this article?

Thanks for your feedback.